Stoke Therapeutics Appoints Eric Olson as Chief Business Officer
Slice of Healthcare Team
09/06/2024
Key Highlights
- Eric Olson named Chief Business Officer at Stoke Therapeutics
- Olson brings over $15 billion in transaction experience from Alnylam and Takeda
- Will lead corporate strategy and business development at Stoke Therapeutics
Source: Business Wire
Notable Quotes
“ We see a significant opportunity to expand the potential of Stoke’s first-in-class, disease-modifying approach to the treatment of many genetic diseases… ”
Edward M. Kaye, M.D., CEO at Stoke Therapeutics
“ I’ve had the opportunity to work on significant advances in RNA therapeutics and rare diseases and look forward to working with the leadership team at Stoke… ”
Eric Olson, Chief Business Officer at Stoke Therapeutics
